About
Christian Schubert is a hybrid operator-investor who shapes corporate venture strategy across US, Europe and Asia‑Pacific, pairing genetics, neurobiology and biochemistry training with large‑pharma experience and active biotech board involvement.
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtech
Experience
- AbbVieVice President and Global Head, AbbVie Venturescurrent2022 — presentCambridge, MA
- Mozart Therapeutics, IncMember | Board of Directorscurrent2023 — presentSeattle, Washington, United States
- Zag BioMember | Board of Directorscurrent2023 — presentCambridge, Massachusetts, United States
- DISCO Pharmaceuticals GmbHMember | Board of Directorscurrent2023 — presentCologne, North Rhine-Westphalia, Germany
- ReAx BiotechnologiesMember | Board of Directorscurrent2023 — presentChicago, Illinois, United States
- Dimericon TherapeuticsMember | Board of Directorscurrent2023 — presentZurich, Switzerland
- Soufflé TherapeuticsObserver | Board of Directorscurrent2024 — presentWatertown, Massachusetts, United States
- Umoja BiopharmaObserver | Board of Directorscurrent2023 — presentSeattle, WA
- Aquinnah PharmaceuticalsObserver | Board of Directorscurrent2023 — presentCambridge, Massachusetts, United States
- Blackbird LaboratoriesAdvisory Board Membercurrent2025 — present
- Alexandria LaunchLabsAdvisor | Seed Capital Platformcurrent2023 — present
- Bakar Bio LabsAdvisor | Bakar Bio Labscurrent2023 — present
- DG MedicinesObserver | Board of Directors2023 — 2025Boston, Massachusetts, United States
- Enthera PharmaceuticalsMember | Board of Directors2023 — 2024Milan, Lombardy, Italy
- Enthera PharmaceuticalsObserver | Board of Directors2023Milan, Lombardy, Italy
- Ribometrix Inc.Member | Board of Directors2023 — 2024Durham, North Carolina, United States
- Portera TherapeuticsMember | Board of Directors2023 — 2024East Lansing, Michigan, United States
- Ambagon TherapeuticsMember | Board of Directors2023 — 2024San Francisco, California, United States
- SNC Therapeutics, Inc.Member | Board of Directors2023 — 2024Chicago, Illinois, United States
- Ribon TherapeuticsObserver | Board of Directors2023 — 2024Cambridge, Massachusetts, United States
Education
- Harvard Medical SchoolPostdoctoral Fellowship (Boston Children's Hospital), Neuroscience2009 — 2012
- Massachusetts Institute of TechnologyDoctor of Philosophy (Ph.D.), Biological Chemistry2005 — 2009
- Harvard UniversityCertificate, Introduction to Clinical Investigation2010
- Massachusetts Institute of TechnologyCertificate, Teaching and Learning Laboratory2009
- Harvard-MIT Division of Health Sciences and TechnologyCertificate, Graduate Education in Medical Sciences2008 — 2009
- Technical University of MunichMaster of Science (M.Sc.), Biochemistry2003 — 2005
- University of OxfordVisiting Student, St. John's College2004
- Technical University of MunichBachelor of Science (B.Sc.), Biochemistry2000 — 2003
- ETH ZürichSummer Student, Biochemistry2002
Skills & more
Neuroscience14Drug Discovery21Biochemistry19Life Sciences12Biotechnology9Genetics25Molecular Biology1Genomics2Clinical Development6ResearchClinical Trials1Confocal Microscopy1
+2 more
Cell BiologyClinical ResearchLanguages English · French · German · Swedish
From Christian's professional profile.
Same school
Also attended Harvard Medical School118
Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 112 more
Also attended Massachusetts Institute of Technology977
Fred WilsonCo-founder & Partner at Union Square VenturesAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of Varda
+ 971 more
Also attended Harvard University1,230
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures
+ 1,224 more
Also attended Technical University of Munich182
Daan BoekhoudtInvestment Analyst at Cottonwood Technology FundJulian von EckartsbergManaging Director Europe at Burda Principal InvestmentsHannes Voucko-GlocknerInvestment Analyst at Burda Principal InvestmentsThomas MeierPartner, Head of Resilience in Energy & Resources Investments at Verve VenturesNiklas Born de AndrésInvestment & Product Intern at Kibo VenturesItziar EstevezPartner - Growth at Iris Capital
+ 176 more
Shared employers
Also worked at DISCO Pharmaceuticals GmbH3
Colleagues at AbbVie
Anthony Melendez
Managing Director at AbbVie
Christina Vorvis
Director at AbbVie
Claire Leurent
Managing Director at AbbVie
Donmienne Leung
Director II, Head of AbbVie Ventures Europe at AbbVie
Doug Faunce
Executive Director at AbbVie
Joachim Vogt
Director at AbbVie
John Gustofson
Managing Director at AbbVie
Margarita Chavez
Managing Director at AbbVie
.png)



























